Metabolic dysfunction-associated steatohepatitis (MASH) is one of the most common chronic liver diseases, primarily caused by metabolic disorders and systemic inflammatory responses.
CePA: Novel nanomedicine for alleviating MASH via mTOR repression
- Post author:
- Post published:July 16, 2024
- Post category:uncategorized